Analysts at Needham & Company LLC initiated coverage on shares of Ocular Therapeutix (NASDAQ:OCUL – Get Free Report) in a ...

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in ...

Dentsply Sirona (XRAY) stock and ZimVie (ZIMV) stock faced downgraes from Needham due to near-term industry headwinds. Read ...

In a report released today, Kyle Peterson from Needham maintained a Hold rating on Cardlytics (CDLX – Research Report). The company’s shares ...

Equities researchers at Needham & Company LLC initiated coverage on shares of Backblaze (NASDAQ:BLZE – Get Free Report) in a note issued to investors on Tuesday, MarketBeat reports. The brokerage set ...

Fintel reports that on March 13, 2025, Needham downgraded their outlook for ZimVie (NasdaqGS:ZIMV) from Buy to Hold. Analyst ...

Needham downgraded Dentsply Sirona and ZimVie to Hold from Buy, citing a lack of near-term catalysts and continued weakness in the dental market.

In a report released today, Kyle Peterson from Needham maintained a Hold rating on TriNet Group (TNET – Research Report). The company’s shares ...

Fintel reports that on March 13, 2025, Needham downgraded their outlook for DENTSPLY SIRONA (NasdaqGS:XRAY) from Buy to Hold. Analyst Price Forecast Suggests 36.66% Upside As of March 4, 2025, the ...

Imported wine, champagnes, and other alcoholic products from the European Union are the latest targets of President Trump's ...

Needham downgraded Dentsply Sirona and ZimVie, citing weak growth, market share losses, and demand challenges amid high ...

The vast and dizzying array of business entities created by collapsed ATM network operator Daryl Heller over the past 16 ...